The estimation of selected endogenous anticoagulation system parameters in patients with subclinical Cushing's syndrome

Eur J Endocrinol. 2011 Dec;165(6):865-71. doi: 10.1530/EJE-11-0535. Epub 2011 Sep 13.

Abstract

Objective: An increased tendency towards thromboembolic events is observed in patients with Cushing's syndrome. There are much fewer publications available about thromboembolic complications in patients with subclinical Cushing's syndrome (SCS). Therefore, a question arises whether hemostatic disturbances appear in this particular disease phase.

Aim of study: Estimation of protein C (PC), free protein S (FPS), antithrombin (AT) activity, thrombomodulin (TM) concentration and activated PC resistance (APCR) in patients with SCS.

Materials and methods: We studied 35 patients with SCS. The control group consisted of 33 healthy volunteers. The activity of PC, AT, FPS, APCR and the concentration of TM was estimated in all representatives.

Results: The comparison of the examined coagulation parameters between the patients with SCS and the healthy individuals revealed significantly higher mean PC activity and mean FPS activity in the SCS group. Mean TM concentration was significantly lower in patients with SCS compared with the control group. The differences in APCR and AT activity were not significant. We did not prove any statistically significant correlations between the examined coagulation parameters and hormonal parameters. We did not find any correlation between the concentration of cortisol and basic coagulation parameters such as international normalized ratio, activated partial thromboplastin time or fibrinogen in the group with SCS either.

Conclusions: The patients with SCS present disturbances in endogenous anticoagulation system defined as PC, FPS activity and TM concentration. This finding suggests an impact of mild autonomic cortisol overproduction on coagulation system.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Anticoagulants / blood*
  • Blood Coagulation / physiology*
  • Cross-Sectional Studies
  • Cushing Syndrome / blood*
  • Cushing Syndrome / diagnosis*
  • Cushing Syndrome / epidemiology
  • Female
  • Humans
  • Male
  • Middle Aged
  • Protein C / metabolism
  • Protein S / metabolism
  • Thromboembolism / blood
  • Thromboembolism / diagnosis
  • Thromboembolism / epidemiology
  • Thrombomodulin / blood

Substances

  • Anticoagulants
  • Protein C
  • Protein S
  • THBD protein, human
  • Thrombomodulin